Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.

  title={Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.},
  author={Ali Mohammed Yahya Haidar and Morten Jǿnler and Troels Bille Folkmar and Lars Lund},
  journal={Scandinavian journal of urology and nephrology},
  volume={43 6},
OBJECTIVE The use of bisphosphonates (zoledronic acid) in the treatment of metastatic bone disease has been raised during recent years. The purpose of this treatment is mainly to reduce skeletal-related events, e.g. pain and pathological fractures. The aim of this study was to report the incidence of bisphosphonate-related osteonecrosis of the jaw (ONJ… CONTINUE READING